Implementation Steering Committee / National Centre for Immunisation Research and Surveillance / office of Health Protection / Australian Health Protection Principal Committee / Working Party / Communicable Disease Intelligence / Therapeutic Goods Administration / Advisory Committee on the Safety of Vaccines / Australian Government / National Immunisation Committee / Department of Health / Working Party of Experts / HPV AEFI / /
Person
John Horvath / Chris Baggoley / Nicole Gilroy / /
Position
Chief Medical Officer / Professor / Minister / consultant physician / Secretary / /
REVIEW OF THE MANAGEMENT OF ADVERSE EVENTS ASSOCIATED WITH PANVAX AND FLUVAX (HORVATH REVIEW) OUTCOMES OF RECOMMENDATIONS INTRODUCTION Following an increase in febrile convulsions associated with influenza vaccine in chi